진단 시약 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Diagnostic Reagents Market size is expected to reach USD 120.21 Billion in 2034 from USD 65.55 Billion (2025) growing at a CAGR of 6.97% during 2026-2034.

The Global Diagnostic Reagents Market is witnessing steady expansion due to the increasing demand for accurate and early disease detection. Rising prevalence of infectious diseases, cancer, and chronic disorders has accelerated the use of diagnostic kits and reagents across hospitals and laboratories. Growth in clinical testing volumes, especially post-pandemic, continues to strengthen market momentum worldwide.

Key drivers include advancements in molecular diagnostics, immunoassays, and point-of-care testing technologies. The growing elderly population and increasing healthcare awareness are further boosting diagnostic testing rates. Additionally, government initiatives to enhance laboratory infrastructure and expand screening programs in emerging economies are contributing to sustained market development.

Looking ahead, the market is expected to benefit from automation, personalized medicine, and AI-integrated diagnostic platforms. Continuous innovation in reagent formulations and the rising adoption of companion diagnostics will support long-term growth. Expansion of home-based and rapid testing solutions is likely to open new revenue streams in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Chromatography Reagents
• Molecular Diagnostic Reagents
• Immunoassay Reagents
• Clinical Chemistry Reagents
• Flow Cytometry Reagents
• Cell And Tissue Culture Reagents
• Hematology And Hemostasis Reagents
• Microbiology Reagents
• Others

By End-user

• Hospitals And Diagnostics Laboratories
• Academic And Research Institutes
• Others

COMPANIES PROFILED

• Abbott Laboratories, F HoffmannLa Roche AG, Becton Dickinson and Company, Siemens Healthineers, Sysmex Corporation, DiaSorin SpA, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc, Agilent Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Chromatography Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Molecular Diagnostic Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Immunoassay Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Clinical Chemistry Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Flow Cytometry Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Cell And Tissue Culture Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Hematology And Hemostasis Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Microbiology Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals And Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DIAGNOSTIC REAGENTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 F. Hoffmann-La Roche AG
  • 8.2.3 Becton Dickinson And Company
  • 8.2.4 Siemens Healthineers
  • 8.2.5 Sysmex Corporation
  • 8.2.6 DiaSorin S.P.A
  • 8.2.7 BioMerieux SA
  • 8.2.8 Ortho Clinical Diagnostics
  • 8.2.9 Thermo Fisher Scientific Inc
  • 8.2.10 Agilent Technologies Inc